eyes and alkalis

Wave of paediatric eye injuries from liquid detergent capsules
We highlight a new wave of paediatric ocular surface injuries. In our case series of 13 children (mean age 23.9 months, range 14-34 months; nine girls), corneal burns resolved with no sequelae in 12 cases (table). However, one child (case 1) received ocular irrigation only on arrival in accident and emergency and therefore sustained bilateral total corneal epithelial burns.
The capsule in most liquid detergent capsules is a water soluble polyvinyl alcohol membrane. The liquid detergent is a mixture of three active agents-an anionic detergent (20-30%), a non-ionic detergent, and a cationic surfactant-dissolved in water to give an alkaline solution, making the capsule more dangerous than initially perceived.
Alkali injuries are the most severe form of ocular chemical injury and can cause irreversible damage to all anterior ocular structures and have lifelong ramifications.
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Any visual deprivation from a non-healing corneal epithelial defect or from subepithelial scarring in children can also lead to amblyopia.
After recent discussions with Guy's Poisons Unit, some manufacturers have made hazard labels more prominent. But greater consumer awareness is required to reduce injury. Such concentrated cleaning products must be kept out of the reach of children, and immediate irrigation is crucial to reduce the risk of clinically significant injury.
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O'Driscoll AM, Shah P, Aggarwal RK, Chell P B, Hope- The National Patient Safety Agency considers emergency oxygen treatment in adults, focusing on chronic obstructive airways disease.
1 The acute coronary syndrome is also commonly treated with oxygen according to MONA (morphine, oxygen, nitroglycerine, aspirin)-a mnemonic imprinted on the memory of every medical student and junior doctor. However, this use of oxygen is based more on historical precedent than evidence. Research into coronary physiology suggests that blanket oxygen administration may do more harm than good.
A recent systematic review showed that high concentrations of oxygen reduce coronary blood flow. In subjects with coronary heart disease a reduction of up to 28.9% was observed; a phenomenon that may potentiate myocardial ischaemia.
2 This is consistent with previous research showing that oxygen treatment can increase infarct size in uncomplicated acute coronary syndrome. No need to flag up potassium
Floyd raises concern about several "sports" and "detox" drinks having potassium concentrations over 80 mg/100 ml, as well as "one with a heart stopping boast of over 200 mg/100 ml." Guidance needed on secondary effects of cS gas on staff
We agree with Carron and colleagues that tear gas, especially chlorobenzylidene malononitrile (CS gas), has multiple effects. 1 We encountered a case in which a 27 year old man was sprayed with CS gas by police. He sustained mixed thickness burns to his face, trunk, and upper arms and was managed by isolation in a cubicle room. According to his medical records, he had experienced similar sequelae three years earlier with a similar pattern of burns.
Despite reports of sensitisation to the effects of CS gas, 2 our initial suspicions of sensitisation were unfounded in this case. We were, however, concerned about the potential secondary effects on healthcare professionals who come into contact with people who are sprayed with CS gas. Secondary effects have been reported in anaesthetists intubating a patient with laryngospasm who had been sprayed with CS gas only 10 hours previously. 3 In the US such effects have been reported regularly among accident and emergency staff.
4 5 Furthermore, people can be sensitised to the effects of CS gas after repeated exposure. In one case the patient required intravenous antibiotics and systemic steroids on the second, separate, exposure to CS gas. Healthcare professionals need guidance to help to reduce the chances of secondary exposure to irritant substances such as CS gas. CS gas lingers in hair and skin and therefore decontamination must form part of patient management (figure). This goes against a key recommendation of the report to create fair employment, good working conditions, and strengthen disease prevention. For all the good that this report will do, many communities will continue to lag behind in social and healthcare provision, and in my own community the average person will die far earlier than the seven years predicted by the report.
In times of recession, stating that we should, "put sustainability and wellbeing before the narrow focus of economic growth, and to bring about a more equal and fair society" 2 is all very well, but in reality budgets have to be adhered to and without money to invest, the health gap in my town is increasing quicker than the nations' debt. 
Timing is everything
Matching the timing of individual, family, and community interventions to the critical stages of child development is essential for the future health of the public.
1 Even in an affluent nation like England, professional help such as specialist public health nursing rarely seems to reach the most disadvantaged children when and where it is needed, or on terms that parents and elected local councils can grasp.
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Hertzman and colleagues recognise the role that good environments in the early years play in later physical and mental health.
3 However, successful "programmes to support early child development" need to incorporate responses to parental illness and disability, as well as the economic gradients in society. In England, roughly 10% of households with young children have at least one parent with untreated mental illness (mainly depression); this figure is 8% for untreated alcohol dependence and 7% for disabilities detected when in school but still unresolved in adulthood (including mild learning disabilities). All of these problems are more common and less likely to get medical attention in the poorest communities. Assuming some overlap (comorbidity) within poor households, perhaps 20% of children are dependent on parents with these unresolved conditions. It is not surprising that, in our profile of diverse parenting programmes across a county (population 1.7 million), we found that long serving "parenting practitioners" requested additional training and supervision for problems with alcohol or disability; and they also found that entrenched parental behaviours like domestic violence affected their work across many interventions to improve local childhoods.
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Caan W. Being of sound mind, in the beginning. 
CHroniC fatigue syndrome
More than defeatism greets patients with Me I was diagnosed with myalgic encephalomyelitis (ME) in 2003, referred to the Maudsley for cognitive behaviour therapy and graded exercise therapy, and have recovered fully. When the diagnosis was made I met it with disbelief-I too had misconceptions about ME.
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My immediate colleagues carried me through the first six months when I could hardly function, needing to rest frequently. The managers encouraged me to work the hours I could, recording no sick leave as I came into work daily. Four years later I was working normally and have since taken on a management role.
How much easier it would have been for me to go off sick. But staying at work is one of the most important prognostic factors for patients with ME.
The tragedy of the mother who helped her daughter with ME to commit suicide is that the medical profession let her daughter down. Why do we find ME so hard to deal with? We all accept the effect the psyche has on the physical, so why can't we accept a condition that involves both? I have been told not to admit to having ME and had it discounted from my medical history as if it didn't exist. I have witnessed colleagues making appalling generalisations about people with ME. ME is thought to be a selfish disease and I understand why; but it is also a lonely one, with a huge social and professional stigma. I knew it was down to me to get better-no one else could do it for me, but I could not have beaten it without the help of those around me. I thank them and hope others are as fortunate. Firstly, the media did use Lynn Gilderdale's case to highlight the existence of severe chronic fatigue syndrome (CFS) and the desperate need for biomedical research into the underlying cause. But the coverage did not imply that CFS is a "commonly fatal" condition, and it was premature of the authors to conclude-without epidemiological data-that mortality is not increased.
Secondly, accumulating evidence indicates that the two behavioural treatments offeredcognitive behaviour therapy (CBT) and graded exercise therapy (GET)-can be ineffective (CBT) or harmful (GET).
2 The only research to investigate potential risk factors for the development of severe CFS found no evidence to implicate personality or neurotic traits, 3 so it is disingenuous to claim that the use of these two treatments in a group of patients who cannot normally travel to hospital to access them is going to produce a "dramatic recovery."
Thirdly, in my experience, people with CFS who commit suicide do so because of a combination of factors mainly involving lack of medical care and social support, failure to control key symptoms, and inadequate financial help, and depression is not always present.
People with severe CFS require multidisciplinary services in both a domiciliary and accessible hospital based setting that matches their complex individual needs. Having strongly criticised the current lack of care that is available, we question whether the NHS trusts the authors work for are in fact putting words into action and supplying domiciliary and in-patient facilities for their severely affected patients with CSF.
letters double faCe of disCrimination undertreatment is a problem
As a geriatrician, I see daily the iatrogenic effects of overtreatment of older patients that is partly driven by a box ticking, target oriented culture.
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People are taking drugs they no longer need or may never have needed or that haven't been meaningfully reviewed for some time, despite the quality and outcomes framework.
However, common, serious, and debilitating conditions largely affecting older people tend to be under-recognised and poorly managed while services and research tend to be underfunded and the training of professionals is inadequate. In hospitals older patients with treatable medical problems (often manifesting with loss of physical function or impaired cognition) are written off as "social" or "acopia."
Although ageing should not be routinely medicalised, danger lies in having treatable problems in older people "socialised." Patients over 65 already account for around 70% of bed days in NHS hospitals, but priorities and values have yet to catch up with the fact that frailty, ageing, and long term conditions are core to health. Many patients don't present in "textbook" fashion, and much of medicine is about maintenance or palliation rather than cure, about the commonplace and not the rare and diagnostically challenging, and about low tech rather than high tech interventions. So we have the bizarre paradox of general practitioners being given incentives to treat, say, hypertension or cardiac failure aggressively, while conditions such as continence, osteoporosis, dementia, delirium, and falls are far down the pecking order. 
legislation offers protection
When good people argue in favour of age discrimination in the NHS it is time to despair, or to act, to protect the rights of older people.
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This was my rationale in advocating for legislation on age discrimination in the NHS. The two important caveats were: public health programmes for disease prevention could target age specific groups on the basis of evidence for cost effectiveness; and individual decisions not to treat, made in the privacy of the consultation room, on grounds of personal choice or lack of capacity to benefit-for example, because of frailty-would not be challenged.
Only the denial of access to treatment on the basis of chronological age would be outlawed through the proposed legislation. If passed into law, many will welcome the protection it will afford in later life.
I hope this will include Iona Heath, aged 80 and in excellent health, when she might otherwise be turned down for cost effective treatment of a life threatening illness. Jonathan Gornall has tried to clarify the issues in the MIST trial and NMT Medical's libel action against me, but he has made some errors. 2 The letter before claim from NMT's lawyers also makes that argument, but it does not stand up to scrutiny because: (1) Nugent et al's patients had a different pathology: an atrial septal defect, which produces a left to right shunt, not a PFO [patent foramen ovale], which produces a right to left shunt (2) Nugent et al's technique for detecting a residual shunt, colour flow Doppler echocardiography, was different and less sensitive than contrast echocardiography used in the MIST trial (3) It would not be surprising if the authors get particularly good results when implanting STARFlex because Lock, the senior author, has the longest experience with the device, having been one of its inventors. In contrast, implanting cardiologists in the MIST trial were required to have done a "minimum of 10 PFO closure procedures." Gornall states that Missault reported that 33 patients had residual shunts. The correct figure is 38. Gornall's breakdown into types is wrong. Missault classified 29 as pulmonary, four as atrial, and five as "unknown origin." Gornall states that I reported that 27 patients had shunts. I actually reported 40 shunts compared with Missault's 38. However, we respectively assessed 22 and 14 of the shunts as large enough to be significant. Gornall states: "The paper was endorsed by the other 22 doctors involved in the trial." This figure appears to be derived from adding the number of named authors to the number of named contributors who were not NMT employees.
3 This figure does not take into account the fact that some contributors had no medical qualification and one medically qualified "author" died in May 2004, six months before the trial started. 4 Most authors had no role in trial design (because no author was a member of the MIST Trial Design Physicians Advisory Group), administration, data interpretation, or writing the paper. Gornall states: "According to a note he made of a meeting with NMT's chief executive on 16 September 2005, Dr Wilmshurst was aware of these issues (share holdings by some members of the steering committee) then but did not consider resigning from the trial." My note makes no mention of whether I considered resignation. Neither NMT nor Gornall know whether I considered resignation. Resignation would have been the easy way out. As my concerns about the trial increased, the more I felt compelled to remain involved to ensure that the data were accurately presented. In fact, throughout the MIST trial I have made many choices where others might have found it easy to do otherwise. I could have accepted the £50 000 consultancy fees offered by NMT. I declined to avoid a conflict of interest. Because NMT was insistent on providing the money, I asked for it to be donated to charities with no possible connection to me-the Disasters Emergency Relief Fund for the Boxing Day Tsunami and a South African charity for children with AIDS. I could have accepted inaccuracies in reporting the paper, and I would probably have been the first author. I could have kept quiet and avoided a libel action.
